Searchable abstracts of presentations at key conferences in endocrinology

ea0080p5 | Abstracts | UKINETS2021

Real world overall survival in patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) in a large United Kingdom (UK) tertiary centre

Clement Dominique , Brown Sarah , Halim Mohammed , Dolly Saoirse , Kibriya Nabil , Howard Mark , Prachalias Andreas , Menon Krishna , Srinivasan Parthi , Ramage John , Srirajaskanthan Raj

Introduction: The incidence and prevalence of GEP-NENs is rising worldwide. NENs represent the group off well differentiated neuroendocrine tumours (NET) and poorly differentiated neuroendocrine carcinoma (NEC). NETs can be divided into grade 1 (G1), grade 2 (G2) and grade 3 (G3) based on histological parameters. There exist several studies regarding survival data but these are mainly based on national databases.Aim: To describe the real world overall su...

ea0046oc2 | (1) | UKINETS2016

Tumour size is not a reliable criterion for management of patients with Non-secreting pancreatic neuroendocrine tumours: results of a large, multi-centre, operative cohort

Mills Logan , Drymousis Panagiotis , Vashist J , Burdelski C , Prachalias Andreas , Srinivasan Parthi , Menon Krishna , Khan Saboor , Cave Judith , Armstrong Thomas , Weickert MO , Frilling Andreja , Ramage JK , Srirajaskanthan Raj

Background: Small pancreatic neuroendocrine tumours (PNETs) present a management dilemma because of their uncertain natural history. Some clinicians believe that lesions <2 cm are indolent and can be managed with surveillance. By contrast, the most recent WHO classification system regards all PNETs as potentially malignant.Aim: To assess the malignant behaviour of small PNETs in a large, retrospective, multicentre patient cohort.<p class="abstext...